Style
ValueTurnover
Orientation
Concentrated trader| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | GH Research PLC(GHRS) | 13,263,288 | $356.5M | 41.19% |
| 2 | Cullinan Therapeutics Inc(CGEM) | 8,963,500 | $163.2M | 18.86% |
| 3 | Stoke Therapeutics Inc(STOK) | 4,038,404 | $132.1M | 15.27% |
| 4 | Agios Pharmaceuticals Inc(AGIO) | 3,408,937 | $126.5M | 14.62% |
| 5 | C4 Therapeutics Inc(CCCC) | 7,326,691 | $34.2M | 3.95% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 75.73% | 58.67% | -17.06% |
| Unclassified | 24.27% | 41.33% | +17.06% |
Quarter-over-quarter weight changes by market cap
| 6 |
| Korro BIO Inc(KRRO) |
| 1,538,296 |
| $20.3M |
| 2.34% |
| 7 | Tscan Therapeutics Inc(TCRX) | 8,019,148 | $7.9M | 0.91% |
| 8 | Precision Biosciences Inc(DTIL) | 950,466 | $7.5M | 0.86% |
| 9 | Neuphoria Therapeutics Inc(NEUP) | 875,328 | $3.8M | 0.44% |
| 10 | Passage BIO Inc(PASG) | 673,759 | $3.3M | 0.38% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Small Cap | 60.26% | 48.97% | -11.29% |
| Unclassified | 24.27% | 41.33% | +17.06% |
| Micro Cap | 9.42% | 9.4% | -0.02% |
| Mid Cap | 6.04% | 0.29% | -5.75% |
Quarter-over-quarter position changes